Multiple comparisons of receptor sequences, or receptor subunit sequences, has proved to be an invaluable tool in modern pharmacological investigations. Although of outstanding importance, general sequence databases su¡er from several imperfections due to their size and their non-speci¢city. Room therefore exists for expert-maintained databases of restricted focus, where knowledge of the research ¢eld helps to ¢lter the huge amount of data generated. Accordingly, neuroscientists have designed databases covering several types of proteins, in particular receptors for neurotransmitters.
INTRODUCTION
The comparison of the multiple sequences revealed by molecular cloning has driven a complete revolution of modern biological research. Gilbert (1991) referred to à paradigm shift in biology', in which experiments would be designed by the analysis of existing data using bioinformatic and biocomputational methods. This paradigm shift partly arose from the analyses of sequences and their comparison. In pharmacologyöthe study of drug receptors, their interactions with their ligands, and the consequences of these interactions for living matteröthe revolution has been deep. It has a¡ected both the theoretical and the methodological frameworks driving the investigations performed in the ¢eld.
Pharmacological diversity is indeed crucial to an understanding of the physiology of the organism and, in particular, of the nervous system. Many receptors for neurotransmitters are made of homologous subunits, coded by genes derived from a common ancestor. In the ionotropic receptors, for instance, the sequence variability between homologous subunits may generate di¡erences in the permeability properties and in the a¤nities of the various structural states for the ligands. In turn, those variations not only a¡ect binding events at a given concentration of ligand, but also a¡ect the kinetics of the allosteric transitions between the di¡erent structural states. Consequences range from variation in mean opening time to modi¢cation of the desensitization properties (Galzi et al. 1996) .
THEORETICAL INTEREST OF MULTIPLE SEQUENCE COMPARISONS
The discovery, for almost every kind of receptor, of numerous homologous genes, both orthologous (genes appearing by speciation) and paralogous (genes appearing by duplication within a species), challenged what we could call the`typological thought'. It was a tacit rule to de¢ne, for each kind of receptor, what the palaeontologist s call a`holotype', that is a particular receptor considered as the model for the whole groupö the other members being de facto de¢ned with reference to this one (see the example of the nicotinic acetylcholine receptor of the Torpedo electric organ, for instance). The wealth of homologous sequences revealed a much more nuanced picture, with a continuum of variation invalidating the typological thought, and providing a basis for the wide and puzzling pharmacological spectra observed.
As a consequence, another conceptual outcome of the multiple sequence comparisons has been to modify the classi¢cation of receptors. Receptor classi¢cations are heuristic and our understanding of a receptor family, namely the function of its di¡erent members and their relationships, is biased by its subdivisions and the notions hidden behind the name of each member. Indeed, a useful classi¢cation of any group member (or element) is that, within one group, the elements have more relationships between themselves than with any element of any other group. Such a classi¢cation can often lead to the elimination of numerous wrong directions for research.
The classical pharmacological classi¢cations were based on ligand speci¢cities because they were the ¢rst available data. Due to the typological thought, the classi¢cations were often based on one particular ligand considered to be`informative' or`relevant'. This notion of relevance is largely subjective and driven by the type of study as well as the scienti¢c background of the investigator. As a consequence, the emphasis on di¡erent characteristics has led to di¡erent classi¢cations, the choice between them often being rather arbitrary. Moreover, these classi¢cations have had to be constantly re-examined in parallel with the increases in knowledge.
The International Union of Pharmacology (IUPHAR) Committee on Receptor Nomenclature and Drug Classi¢-cation recommended the integration of structural, operational (or pharmacological) and transductional data (Kenakin et al. 1992) . However, because the functions of proteins depend on their three-dimensional structure, and because this structure is encoded in their amino-acid sequence, the operational and transductional characteristics strongly rely (although sometimes in a complex way) on the structural characteristics. Moreover, from a more theoretical point of view, the e¡ect of a signal is determined by the receptor itself and not by the ligand. This is true at the cellular level; that is, the ¢nal e¡ect upon the cell function of acetylcholine, for instance, depends on the receptor structure: a G-protein-coupled device for the muscarinic receptors, or an ionic channel for the nicotinic receptors. This remains valid even if, at the level of a tissue or an organism, we can sometimes speak about the`cholinergic e¡ects' or the`retinoic e¡ects'. Finally, the operational criteria are sometimes misleading. For instance, it is now well documented that the pharmacologies of orthologous receptors, i.e. the`same' receptors in di¡erent species, can di¡er dramatically. Moreover, in the case of polymeric receptors the ligand binding sites are sometimes located at the interface between subunits. If heteromeric receptors exist, there is no actual one-to-one correspondence between the speci¢c subunits and the particular pharmacological spectra.
The relationship between structure and function of a protein implies that the probability of similar properties for proteins will increase with the similarity of sequences. Even if a given characteristic is in contradiction with this`law', the analysis of many characteristics will reinforce it. The general rule is that the phenotypic similarity will converge to the phylogenetic similarity with the number of characteristics taken into consideration. A good knowledge of the evolutionary relationship of genes, based on careful multiple sequence comparisons, is therefore a most favourable basis for establishing informative and robust classi¢cations of receptors, or receptor subunits.
PRACTICAL ASPECTS OF MULTIPLE SEQUENCE COMPARISONS
Obvious uses of multiple sequence comparisons in pharmacology are the sequence analyses per se, performed, for instance, to unravel the evolutionary history of the receptors (e.g. Le Nove© re & Changeux 1995) or to predict certain structural features (e.g. Le Nove© re et al. 1999). But the information derived from multiple sequence comparisons can also be of outstanding interest for other kinds of experiments.
The study of the molecular evolution of gene families is necessary to fully understand the current relationships between their members. In addition to the light shed on known proteins, the molecular phylogeny sometimes permits the discovery of new proteins. For instance, the existence of the dopaminergic receptor D1c was predicted from molecular phylogenies, and it was thereafter cloned (Cardinaud et al. 1997) . Another example is the cloning in silico of the prokaryotic glutamate receptor (Chen et al. 1999) . The gene was already present in the generalpurpose sequence databases, but was not properly annotated. Only a careful screen based on an iterative multiple alignment process (with the program PSI-BLAST; Altschul et al. 1997 ) permitted its discovery.
Careful analyses and comparisons of known nucleic acid sequences have led, and still lead, to the discovery of new homologous genes using cloning`by similitude'. To perform the cloning we need adequate probes (or adequate primers for the PCR approaches), i.e. we need to know the closest sequences in the family. If we are able to infer, only by its phenotypical properties, the probable molecular position of a given receptor in the family, we should be able to improve the probability of success of the research. The design of primers has to incorporate enough diversity to maintain a good speci¢city, while nevertheless retaining su¤cient conservation to grant good hybridization with the template. The best way to tackle this kind of problem is typically to perform a careful multiple sequence analysis to determine the optimal primers, and not simply to choose primers in the most conserved or the most variable regions as is often the case.
The study of the structural organization of receptors obviously relies on careful analysis of their sequences, for instance setting up experiments of site-directed mutagenesis (e.g. Galzi et al. 1992) or constructing chimeric proteins (e.g. Corringer et al. 1998) . There are already numerous possibilities for mutations of a single residue. However, understanding the functional structure of receptors often requires taking into account local interactions between several residues. The combinatorial possibilities therefore explode, impeding any exhaustive investigation. The parallel comparisons of existing receptor sequences and functional characteristics restrain the space of interesting modi¢cations within bench possibilities.
Consideration of multiple sequence alignments in the 1980s also boosted the accuracy of structure prediction (Rost & Sander 1996) . Feeding the programs with multiple alignments resulted in distinction of the informative variability from the evolutionary noise. The quality of the multiple alignments therefore became an important factor driving the accuracy of the predictions.
Finally, although more indirectly, almost every design of an experiment in molecular biology involves a step of sequence comparisons. Not only is the preparation of the experiment based on sequence analysis (e.g. design of PCR primers, in situ hybridization probes, or choice of epitopes to produce speci¢c antibodies), but its interpretation is also directed by the knowledge of the level of sequence resemblance (for instance the amount of cross-hybridization of probes or cross-recognition of antibodies).
All the experiments described above require fast access to a complete and accurate set of the sequences already known. To be e¤ciently used, those sequences have to be trustworthy, i.e. they have to contain a minimal number of errors (ideally none, of course), and they have to be available in a format that is immediately usable.
DEFECTS OF THE GENERAL SEQUENCE DATABASES
Most of the biological sequences uncovered so far are stored primarily in enormous public databases (Benson et al. 2000; Stoesser et al. 2001; Tateno et al. 2000) . Those repositories are growing at a fast rate, which recently switched from geometric to exponential with the generalization of high-throughput sequencing of complete genomes (they contained ca. 9.6 billion nucleotides at the beginning of September 2000).
Although of outstanding importance, the general sequence databases su¡er from several defects due to their size and their broad purpose. First of all, unwanted errors are sometimes made during the submission process; those errors are not always corrected. In addition, each gene is often represented by multiple entries. This multiplicity is generated from intrinsic causes, such as alternative splicing or editing, from methodology, for instance cDNA versus genomic cloning, but also from competition between laboratories, each submitting its own clone. For instance, the cDNA coding for the human nicotinic acetylcholine receptor subunit a7 is present in at least 11 di¡erent EMBL entries.
If a certain level of curation is sometimes achieved for the protein sequence repositories such as SWISS-PROT (Bairoch & Apweiler 2000) and PIR (Barker et al. 2000) , for practical reasons this is almost never the case for the nucleic acid sequence repositories (the treatment of the 6400 new submissions entered daily in EMBL at the end of 1999 would require a prohibitively large number of highly skilled curators).
Finally, because of the lack of ¢rm rules to select the name and the de¢nition of the entries, the retrieval of a particular sequence within a general database can be cumbersome. For instance, the following three de¢nitions are extracted from public database entries:
Hu man mRN A for muscle ace t y lcholi n e re ce pt or alpha-su bun i t . M ou se mRN A for muscle n i cot i n i c ace t y lcholi n e re ce pt or alpha. H. sapi e n s n i cot i n i c re ce pt or alpha 5su bun i t mRN A , comple t e cd s.
Searches with the keywords`acetylcholine' or`nicotine' would here both result in a partial retrieval.
A more reliable approach is often the screening of the database with a known sequence using tools such as BLAST (Altschul et al. 1997) or FASTA (Pearson & Lipman 1988) . However, this process itself requires some preexisting knowledge of the sequences (such as the variability of the sequences across species and subtypes, as well as the distribution of this variability along the sequence) to use those tools e¤ciently. Moreover, the resulting output is generally not usable, in a raw state.
There is therefore room for expert-maintained databases, of restricted focus but higher quality, where the knowledge of the research ¢eld would help to ¢lter the huge amount of data generated.
The computing tools needed to establish the databases have been in existence since the end of the 1970s, when the main sequence and structure databases were established. It was already possible to access the databases remotely öthe`Internet' was established back in the 1960s. However, those activities were still restricted to specialists. Two concomitant events drastically changed the handling of public data. The development of the World Wide Web provided a convenient tool to access a wide range of objects transparently. In parallel, a computer appeared on almost every scientist's desk, and was quickly connected to the global network.
Almost every researcher in the life sciences had (and probably still has) their own data collection, sometimes in notebooks, sometimes in a personal computer. That was especially true for the molecular biologists who carefully recorded the sequences. With the spreading of the network, they were henceforth able to make this knowledge widely available to the scienti¢c community.
SEQUENCE DATABASES IN THE NEUROSCIENCE S
The increasing size of the multigene families coding for proteins of neurobiological interest, and particularly for pharmacological receptors, gave rise to specialized sequence repositories. Those databases contain nucleic acid and protein sequences as well as atomic structures, when they are available. In addition, they often provide a ¢rst generation of sequence analysis, i.e. multiple sequence alignments and phylogenetic analysis (table 1). Note that the frequency of update is highly variable, and some of these databases could currently be moribund.
Although most of the databases deal with the ¢elds of G-protein coupled receptors and extracellularly activated ligand-gated ion channels, some other collections exist, for instance ESTHER (Cousin et al. 1998) . This server, created in 1994, is dedicated to the analysis of protein and nucleic acid sequences belonging to the superfamily of alpha/beta hydrolases, homologous to cholinesterases. The database was still maintained in January 2001.
The Receptor database intends to cover the protein sequences of all types of receptors (Nakata et al. 1999) . To achieve this ambitious goal, the entries are just unprocessed duplicates of the PIR and SWISS-PROT entries, although carefully ordered. In addition, the database provides secondary structure predictions for each protein presented (note that the predictions are performed with NNPREDICT, a program of very low accuracy according to current standards; see Lesk (1997) ). It seems that the focus of the database is restricted to mammals. The database was still maintained in December 2000.
The G-protein-coupled receptors are monomeric transmembrane proteins that sometimes associate in dimers (Zoli et al. 1993) . Signal transduction is mediated by the physical interaction with GTP-activated proteins, which in turn act on a wide range of e¡ectors such as enzymes or ionic channels (Morris & Malbon 1999) .
The G protein Coupled Receptor Database (GCRDB) was one of the ¢rst receptor databases to be established, back in 1989, and is still one of the most complete dealing with Gprotein-coupled receptors (Kolakowski 1994 ). It contains a
The Ligand Gated Ion Channel database N. Le Nove© re and J.-P. Changeux 1123 huge amount of cleverly organized data. The last update of the GCRDB was made in August 1999. This database is now part of a network integrating the di¡erent databases dealing with G-protein-coupled receptors, organized around the G Protein-Coupled Receptor Data Base (GPCRDB) (Horn et al. 1998) .
The Olfactory Receptor DataBase (ORDB) is focused on a particular group of G-protein-coupled receptors, the olfactory receptors (Skoufos et al. 1999) . It was still maintained in December 2000.
Finally the GRAP lists all the mutants available for Gprotein-coupled receptors (Kristiansen et al. 1996) . It was still maintained in November 2000.
Ligand-gated ion channels (LGIC) are polymeric transmembrane proteins. Their physiological e¡ect is mediated by the opening of an ionic channel upon the binding of a particular ligand. We will not deal here with the intracellularly-activate d ion channels such as the receptors for inositol phosphate and cyclic nucleotides, but only with the extracellularly-activate d LGIC, largely responsible for the fast response to neurotransmitters.
Two main databases collect the sequences of LGIC. Apart from the LGICdb presented below, the recently created GABAagent is focused on the receptor subunits homologous to the GABA ionotropic receptor subunits (Rachedi et al. 2000) . It contains an unprocessed duplication of entries coming directly from the general purpose sequence databases. It is currently impossible to know how up-to-date the repository is.
THE LIGAND GATED ION CHANNEL DATABASE
The last two decades have revealed an unexpected wealth of genes coding for LGIC subunits. The Ligand Gated Ion Channel database (LGICdb) has been developed to handle this growing knowledge, initially during a molecular phylogenetic survey of the nicotinic receptor subunits (Le Nove© re & Changeux 1995). It was made available via the World Wide Web in 1995 and has since been described succinctly in the literature ). The LGICdb's scope is currently limited to the extracellularly-activate d transmitter-gate d channels, i.e. the superfamilies 1.1, 1.2 and 1.5 of Barnard (1996) .
The`cys-loop' superfamily (nicotinic receptors, GABA A and GABA C receptors, glycine receptors, 5-HT 3 receptors and some glutamate-activate d anionic channels) contain receptors made up of ¢ve homologous subunits (Galzi & Changeux 1994; Ortells & Lunt 1995) , each containing a characteristic loop of 13 residues £anked by cysteines; hence the name. The ATP-gated channels (ATP P2X receptors) are at this stage considered to be made up of three homologous subunits (Nicke et al. 1998) . Finally, the cationic channels activated by excitator y amino acids (NMDA receptors, AMPA receptors, kainate receptors, etc., often referred to as cationic glutamate receptors) are made up of four homologous subunits (Dingledine et al. 1999) . The members of the three superfamilies are not homologous, i.e. the gene coding for the subunits does not derive from a common ancestral gene. Accordingly, those subunits are not expected to display the same threedimensional structure and have di¡erent transmembrane organizations ; see ¢gure 1.
The release 24 of the LGICdb ( January 2001) contained 380 subunit entries belonging to 37 di¡erent species (table 2). The LGICdb is accessible via the World Wide Web (http ://www.pasteur.fr/recherche/banques/LGIC/LGIC. html), where it is regularly updated.
(a) Structure of the database entries
The database intends to provide one unique entry for each gene, containing annotated nucleic acid and protein sequences, together with references to the cloning articles and the relevant accession numbers for other databases.
Contrary to numerous other types of data (see the other papers in this issue), the sequences are rather simple pieces of data. The sequence itself has just one dimension: a string of characters, and the surrounding information (references, various annotations) can be attached on the same level.
The structure of the LGICdb inner ¢le containing the data (also called the`£at ¢le') is exempli¢ed below, with the entry A CHsadd m (only an informative subset of this entry's information is displayed; see ¢gure 2 for the complete entry). The current format uses a mark-up style resembling those of the typesetting formats L Y X or RTF, that is, a section mark-up remains active until another section mark-up is reached. Each entry possesses a unique, meaningful identi¢er, which permits the immediate classi¢cation of the entry within the database (see below for the naming system).
\CREATION 22/AUG/1999 \LASTMODIF 11/DEC/2000
The date of creation of the LGICdb entry is speci¢ed (which is unrelated to the date of appearance of the sequences related to the entry in the general databases). The date of last modi¢cation of the entry is also provided, which is an important feature used in some other sequence databases in neuroscience (e.g. the GCRDb), which allows, for instance, the automatic generation of customized updates.
\SPECIES Drosophila melanogaster
The two-component name of the species is noti¢ed. The complete classi¢cation, as present in EMBL or GenBank for example, has been omitted because it is of little direct interest. Tables, nevertheless, present the data ordered according to the species systematic (see below).
\DEFINITION
Fruit¯y nicotinic acetylcholine recept\ or SAD subunit (aka alpha2, aka alpha-9\ 6Ab)
A de¢nition of the entry is given in one line. This de¢ni-tion is intended to describe the entry, and not a particular sequence (the backslash, as in all further examples, means a continuation of the same line). This particular subunit has received three di¡erent names, from three di¡erent groups. The most rational, with respect to the whole group of homology, is retained. If the terminologies are logically equivalent, the one used most in the literature is retained. The references to the original publications and submissions to the general purpose databases are presented, one per line. The above example contains two publications by two di¡erent groups, and three direct database submissions, which were all used in the construction of this
LGICdb entry. The references are not currently processed, as in the GCRDB where the authors are separated; it did not appear of primary importance to do so. In addition, the references quoted in the general purpose sequence databases are entered by the submitters, and often contain abbreviations, such as et al., which invalidate the recognition of individual authors. The retrieval of all the
LGICdb entries containing a particular name would, nevertheless, be a trivial task for any pattern recognition program using regular expressions.
The accession numbers of the sequences related to the entry in various databases are presented. For instance, accessions for DDBJ (Tateno et al. 2000) , EMBL (Stoesser et al. 2001) , GenBank (Benson et al. 2000) , SWISS-PROT (Bairoch & Apweiler 2000) and FlyBase (The Flybase Consortium 1999) are presented here.
\NOTES chromosome="3R" The protein sequences published by Sawruk et al (1990) and Baumann et al (1990) are identical and identical to one variant predicted by Celera. On the contrary, at the transcript level, there were many discrepancie s between the two published sequences. The transcript presented here is a fusion of the two published sequences, taking the Celera sequence as a reference.
A section can contain any notes related to the entry or any particular sequence merged into the entry. Those notes will be considered verbatim and thus can be formatted as desired by the submitter (for instance, carriage returns are conserved). Several protein sequences can be entered, separated by \\, together with mRNA and genomic sequences (the sequences in this example are truncated). Spaces, numbers and any letters are accepted (but dashes and question marks, for example, are not permitted). Each sequence may also possess an optional tag, which is used to construct the name of the ¢les generated for this particular sequence. Individual annotations can also be attached, treated verbatim. To accommodate both the planned increase of complexity of the £at ¢les and the multiplication of the userdriven treatments, the current format will soon be converted into an XML-compatible grammar, which will be able to handle nested levels of speci¢cation.
(b) Structure of the database
There is a many-to-one relationship between the transcripts and their corresponding genes, and in most cases the relationship between the transcript and the protein is one-to-one. It is therefore not necessary to consider complex database designs (see, for instance, the extreme simplicity of GenBank and its equivalents).
The £at ¢les are processed by a Perl script which converts the sequences into various usual formats. Currently, the FASTA format (Pearson & Lipman 1988) (one of the simplest) and the GCG format (Devereux et al. 1984 ) (one of the most frequently used) are provided. The script constructs one HTML page per entry (see ¢gure 2) which contains all the information contained in the £at ¢le and, in addition, hyperlinks to the ¢les containing the various sequences and to the relevant entries of GenBank. Finally, the script constructs two tables which allow the database to be browsed by species and entry ID (¢gure 3). Browsable trees which allow the retrieval of entries by homology are also available; these are currently constructed by hand based on expert phylogenetic analyses. If one knows a fragment of a sequence, the database can be quickly screened to retrieve entries presenting similar stretches of residues. This is achieved with the program FASTA (Pearson & Lipman 1988) . The result of the search can be reformatted to give a multiple alignment by the program MVIEW (Brown et al. 1998) . Communication between the di¡erent programs and the generation of the HTML interfaces is performed by the program PISE (Letondal 2000) .
Snapshots of the database are available to be downloaded as compressed archive ¢les. They contain only the £at ¢les, but include the Perl script for reconstructing the whole database.
A uni¢ed system of cascading identi¢cation tags has been set up, which is congruent both with the sequence similarities of the subunits and the pharmacology of the receptors they form. A ¢rst tag, made of three capitalized digits, represents the main endogenous ligand (5HT, ACH, ATP, GAB, GLU, GLY). A second tag, of variable length, identi¢es the ortholog (e.g., a1 for a1, nmr2 for NMDAR2, etc.). Finally a two-digit tag identi¢es the species. The successive tags are cascading, that is, when read from left to right, their meaning is unambiguous within the framework de¢ned by the previous one. For instance, the subunits ACHa1+ and ACHa2+ (where à +' sign means one or more characters) belong to a natural group, both in term of pharmacology and of sequence; all form nicotinic receptors, and all the ACH+ form a monophyletic group. On the contrary, GABa1+ and ACHa1+ do not belong to a natural group. They do not participate to the same type of oligomeric receptors, and the +a1+ subunits do not form a monophyletic group. One can easily extend this explanation to the next level, taking as an example the pair ACHa1hs, ACHa1mm as a natural group, in contrast to the pair ACHa1hs, ACHa2hs.
(c) Construction of the database
The LGICdb is mainly fed from the general-purpose databases (DDBJ, EMBL, GenBank, SWISS-PROT), but also from the contributions of users (see Acknowledgements) and sometimes from published articles. Rather than automatically transforming the £at ¢les of general purpose databases into a LGICdb £at ¢le, as in the GCRDB, every bit of data is thoroughly scrutinized, and manually processed before inclusion in the LGICdb. This has been possible because of the small number of genes involved (until recently) and necessary because of the uneven quality of the original data.
Some mistakes have been detected in the sequences present in the general-purpose databases. Those detections were possible only because the readers of the sequences had a deep knowledge of the ¢eld, and thus identi¢ed improbable stretches of nucleotides or amino acids. Such error screening cannot be performed with the automated procedures available at present. When a clear mistake is identi¢ed, it is corrected either with the help of the paper describing the cloning or by comparison of the di¡erent entries in the general purpose databases.
As stated earlier, it is common to ¢nd redundant entries in the general-purpose databases. In such cases, we tend to keep the bigger clone, assuming that it might contain interesting regulatory sites. Sometimes the ¢nal sequence was obtained by the fusion of several clones to achieve the maximum length. The authors of every clone are, nevertheless, quoted in the ¢nal LGICdb entry.
The information presented in the general sequence databases is sometimes fragmented. In particular, genomic clones contain coding and non-coding sequences. When the description of the gene structure is present in the database entry (determined experimentally or automatically), the putative transcript sequence was reconstructed (although the whole gene remains present in the entry). In the case of genomic sequences, the gene is sometimes coded on the complementary strand, not on the one presented in the general databases. In such a case, we determined the`reverse-complement' of the sequence to present the coding strand in the LGICdb.
When several alternative splicing products exist, all of them are included in one entry, with an explanation entered in the note section. The same rule will apply when the edited subunits of the glutamate receptors are treated. If several authors provide di¡erent sequences, without any obvious mistakes, all of the variants are presented, being considered as alleles.
All these processing steps imply some fading of the speci¢c features of each clone. When several sequences, coming from di¡erent tissues, are merged, the origin becomes irrelevant, because the sequence of a gene coding for a LGIC subunit is supposedly the same in all the cells of an organism (the somatic mutations, considered as abnormalities, cannot be considered in the LGICdb) and therefore has to be suppressed. This loss of experimental precision is the price to pay for greater data accuracy and clarity. It is not, in fact, an actual loss, because the original sequence ¢les are still present in the general-purpose databases. The simple duplication of all the relevant GenBank or EMBL entries, as is often the case in the specialized databases, does not bring much additional information to the user and obfuscates the issue. Moreover, because the DDBJ, EMBL or GenBank will always be more up-to-date, the outcome of such a compilation could actually be a more misleading framework than a potential improvement of e¤ciency for the experimentalist.
In addition to the gene entries, the LGICdb provides atomic coordinates when available. Those coordinates come from experimental determinations but also from modelling work. They are presented as standard PDB ¢les.
Finally, multiple sequence alignments (Clustal format) and expert phylogenetic investigation s are also available.
The database is continuously maintained, although with irregular updates. At the time of writing, approximately one upload is performed per month. New entries are, of course, regularly added, with previous entries updated according to the improvements in knowledge: sequences of proteins and transcripts are completed or corrected, and genomic information added when available.
CONCLUSION
Started back in 1993 as a personal limited collection of regular GenBank ¢les, the Ligand Gated Ion Channel database has grown to a full scale public database, largely acknowledged in the ¢eld of neurotransmitter-activate d channels. In addition to the outstanding knowledge of LGIC subunit sequences it brought to its curators, the LGICdb has been employed by several teams as a reliable source of sequences. Those sequences were subsequently used, for instance, to perform studies of molecular phylogeny or structure predictions, and also to generate multi-purpose sequence alignments. The structure of the database entries has been enriched, and the resulting dataset now incorporates an important body of manually added information beside the raw sequences picked from the general-purpose databases.
With the achievement of the various genome projects, access to the raw sequences is no longer a challenge. On the contrary, the emphasis is more on the ease of retrieval of a particular piece of data, and on the annotations which allow a faster treatment of this data. Moreover, there is evidence that the reliability of sequences found in the general-purpose databases has decreased with the high-throughput sequencing. The post-sequencing treatments, made by experts able to check the quality of the raw data, therefore become more important. The expertmaintained databases can be of outstanding interest for both experimentalists and theoreticians, who rely on the quality of the sequences they use. 
